Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | UNK | UK023AA | OT |
reports that the Pentacel was given to patient past the expiration date with no reported adverse event; Initial information received on 15-May-2025 regarding an unsolicited valid non-serious case received from other health professional. This case was linked to other case US-SA-2025SA146684. This case involves a 4 months old male patient who received expired diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)] date with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided. On 14-May-2025, the patient received 0.5 ml of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Suspension for injection (Unknown strength) with lot UK023AA and 30-Apr-2025 via unknown route in unknown administration site for Immunization with no reported adverse event (expired product administered) (Latency same day) Reportedly, the pentacel was given to 3 different patients past the expiration date. The first injection occurred on 30-Apr-2025, the second on 12-MAY-2025 and the last injection was on 14-MAY-2025. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA146684: